Robert Reiter in Los Angeles, California

Home California Los Angeles

Robert Reiter has Urology as his primary medical specialty. Their primary office is: 200 Ucla Medical Plz in Los Angeles, California. There are 3 additional office locations for Robert Reiter that can be viewed towards the end of their profile.

They're a part of the: The Regents Of The University Of California medical group which has around 42 members. You can call their office at 310-825-0128 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Stanford University School Of Medicine and graduated in 1988 (around 36 years of experience). They are listed as doing telehealth appointments.

Robert Evan Reiter Office Phone and Directions

Robert Reiter
The Regents Of The University Of California
200 Ucla Medical Plz
Los Angeles, California 90095
310-825-0128

Patient Ratings
Please rate your experience with Robert Reiter below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 310-825-0128

Enter a starting address:

Healthcare Info for Robert Reiter

Medical School: Stanford University School Of Medicine
Graduation Year: 1988
The Primary Medical Specialty for Robert Reiter is listed as: Urology
Approximate Years of Experience: 36
PAC (PECOS ID)#: 2062541345
NPI #: 1346269297
NPI Created On: 07/19/2006
NPI Last Updated Listed as: 01/09/2020
Primary Taxonomy Code: 2086X0206X
License Number:
G67515
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Removal of total lymph nodes of both sides of pelvis using an endoscope
Ultrasound measurement of bladder capacity after voiding
Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
Surgical removal of prostate and surrounding lymph nodes using an endoscope
Ultrasound of rectum
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Leuprolide acetate (for depot suspension), 7.5 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788135545

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $105

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135547

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $82

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135551

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $3,950

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 834984313

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HORMONE THERAPY

Name of Drug #1: ORGOVYX

Open Associated Drug #1: 72974-120-01

Payments Total: $142

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833166799

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: ORGOVYX

Associated Drug #2: 72974-120-01

Payments Total: $83

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833166803

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: ORGOVYX

Associated Drug #2: 72974-120-01

Payments Total: $84

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 789140509

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Nubeqa

Open Associated Drug #1: 50419-395-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: Xofigo

Associated Drug #2: 50419-208-01

Payments Total: $1,512

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 789174119

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Nubeqa

Open Associated Drug #1: 50419-395-01

Payments Total: $770

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 853549527

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RADIOPHARMACEUTICAL

Name of Drug #1: PYLARIFY

Open Associated Drug #1: 71258-022-01

Additional Office Locations

1. The Regents Of The University Of California
300 Stein Plaza
Los Angeles, CA 90095
Fl 3 Suite 331
Group Members: 42

Phone: 310-825-0128

Enter a starting address:

2. The Regents Of The University Of California
300 Stein Plz
Los Angeles, CA 90095
Fl 3
Group Members: 42

Phone: 310-825-0128

Enter a starting address:

3. The Regents Of The University Of California
200 Ucla Medical Plz
Los Angeles, CA 90095
Suite 140
Group Members: 42

Phone: 310-825-0128

Enter a starting address:

Urology Professionals in Los Angeles

1.
Richard Ehrlich

200 Ucla Medical Plz
Los-angeles, CA
The Regents Of The University Of California

2.
Richard Ehrlich

300 Stein Plaza
Los-angeles, CA
The Regents Of The University Of California

3.
Richard Ehrlich

300 Stein Plz
Los-angeles, CA
The Regents Of The University Of California

4.
Jacob Rajfer

200 Ucla Medical Plz
Los-angeles, CA
Regents Of The University Of California

5.
Kathy Huen

200 Ucla Medical Plz
Los-angeles, CA
The Regents Of The University Of California

6.
Kathy Huen

300 Stein Plaza
Los-angeles, CA
The Regents Of The University Of California

Providers in The Regents Of The University Of California

1.Anne Ackerman

200 Ucla Medical Plz
Los Angeles Ca 90095-0001
The Regents Of The University Of California
Urology

2.Anne Ackerman

300 Stein Plaza
Los Angeles Ca 90095-0001
The Regents Of The University Of California
Urology

3.Anne Ackerman

300 Stein Plz
Los Angeles Ca 90095-0001
The Regents Of The University Of California
Urology

4.Anne Ackerman

200 Ucla Medical Plz
Los Angeles Ca 90095-3075
The Regents Of The University Of California
Urology

5.Zachery Baxter

200 Ucla Medical Plz
Los Angeles Ca 90095-0001
The Regents Of The University Of California
Urology

6.Zachery Baxter

300 Stein Plaza
Los Angeles Ca 90095-0001
The Regents Of The University Of California
Urology

View all 42 members of The Regents Of The University Of California medical group